Wetteny Joseph has been appointed as president of Catalent’s Clinical Supply Services.
Wetteny Joseph has been appointed as president, clinical supply services for Catalent Pharma Solutions, the company announced on Oct. 22, 2015.
Joseph joined Catalent in 2008 as corporate controller, and in 2012, was charged with leading the finance function for the company’s modified release technologies business unit. in 2013, he was promoted to vice president of finance for Catalent’s Development and Clinical Services division, which included the Clinical Supply Services business unit.
Before joining Catalent, Joseph held senior financial positions at HD Supply, including CFO of a $1.2 billion business unit. He also served as corporate controller at Hughes Supply and spent six years at PricewaterhouseCoopers as an auditor, and as a strategic financial advisor across a variety of industries.
Joseph earned Master’s and bachelor’s degrees in accounting from Florida Atlantic University.
Source: Catalent
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.